Does Rallies show Form 4 insider transactions for RCKT?

Yes. Rallies tracks RCKT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RCKT research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RCKT. It does not provide personalized investment advice.

RCKT (Rocket Pharmaceuticals, Inc. Common Stock) Stock Analysis - Insider Trades

Rocket Pharmaceuticals, Inc. Common Stock (RCKT) is a publicly traded Healthcare sector company. As of May 21, 2026, RCKT trades at $3.05 with a market cap of $335.22M and a P/E ratio of -1.47. RCKT moved +1.37% today. Year to date, RCKT is -16.34%; over the trailing twelve months it is -56.64%. Its 52-week range spans $2.19 to $18.89. Analyst consensus is buy with an average price target of $9.67. Rallies surfaces RCKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RCKT stock inside the company?

Recent RCKT insider activity includes Wilson Martin sold 3.36K, Shah Gaurav sold 2.73K, Militello John sold 855, Chaudhuri Sarbani sold 17.65K, and Militello John sold 1.16K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

RCKT Key Metrics

Key financial metrics for RCKT
Metric	Value
Price	$3.05
Market Cap	$335.22M
P/E Ratio	-1.47
EPS	$-2.01
Dividend Yield	0.00%
52-Week High	$18.89
52-Week Low	$2.19
Volume	820
Avg Volume	0
Revenue (TTM)	$0
Net Income	$-223.12M
Gross Margin	0.00%

Recent RCKT Insider Trades

Wilson Martin sold 3.36K (~$12.12K) on May 13, 2026.
Shah Gaurav sold 2.73K (~$9.84K) on May 13, 2026.
Militello John sold 855 (~$3.08K) on May 13, 2026.
Chaudhuri Sarbani sold 17.65K (~$67.74K) on May 7, 2026.
Militello John sold 1.16K (~$3.86K) on Feb 18, 2026.

Latest RCKT News

Rocket Pharmaceuticals Sells $180M Rare Disease Review Voucher, Extends Cash Runway to 2028 — Apr 28, 2026
Rocket Pharmaceuticals Narrows Q4 Loss, Holds $188.9M Cash as Kresladi Decision Looms — Feb 27, 2026

RCKT Analyst Consensus

13 analysts cover RCKT: 0 strong buy, 7 buy, 4 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.67.

Common questions about RCKT

Who is trading RCKT stock inside the company?: Recent RCKT insider activity includes Wilson Martin sold 3.36K, Shah Gaurav sold 2.73K, Militello John sold 855, Chaudhuri Sarbani sold 17.65K, and Militello John sold 1.16K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RCKT?: Yes. Rallies tracks RCKT insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RCKT research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RCKT. It does not provide personalized investment advice.